Pcyc-1134M-Ca
ClinicalTrials.gov NCT02582879
Research payments
$489,651
Through program year 2020, $489,651 in research payments was reported against Pcyc-1134M-Ca, across 2,033 payments, paid by Pharmacyclics LLC, An AbbVie Company.
- Paid by
- Pharmacyclics LLC, An AbbVie Company
- ClinicalTrials.gov
- NCT02582879
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $489,651 | 2,033 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Burke Aurora, CO Named on 121 payments
- Ryan Hall Little Rock, AR Named on 69 payments
- Ayed Ayed Jacksonville, FL Named on 66 payments
- Daniel Lebovic Grosse Pointe, MI Named on 59 payments
- Habte Yimer Tyler, TX Named on 49 payments
- Daniel Efiom-Ekaha York, PA Named on 46 payments
- Suzanne Fanning Greenville, SC Named on 46 payments
- Shiela Haffar Mesquite, TX Named on 45 payments
- Nilanjan Ghosh Charlotte, NC Named on 37 payments
- Timothy Wassenaar Waukesha, WI Named on 36 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.